tirzepatide starter pack GobyMeds Tirzepatide / Niacinamide Injection |

Cardiovascular Health: Clinical studies have demonstrated that Semaglutide can reduce the risk of major cardiovascular events, such as heart attack and stroke, in individuals with type 2 diabetes

Omega-3s: Support cardiovascular health and potentially help with inflammation

Meet our doctors Last reviewed: 04 Aug 2025 Sources Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison (2022) Diabetes Obesity & Metabolism [accessed 15 June 2025] MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss (2023) Gov.uk [accessed 15 June 2025] Mounjaro (2023) Mounjaro [accessed 15 June 2025] Mounjaro KwikPen 2.5/5/7.5/10/12.5/15 mg solution for injection in pre-filled pen (2024) EMC [accessed 15 June 2025] Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial (2018) The Lancet [accessed 15 June 2025] Weight loss injections NHS weight loss injections GLP-1 for weight loss Can doctors help with weight loss

The result is a smoother recovery, faster return to daily activities, and scars that fade beautifully over time